{"schema_version":"1","generated_at":"2026-11-02T14:46:07.742Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kevin-kalinsky","json_url":"https://www.findmykol.com/kol/kevin-kalinsky/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kevin-kalinsky","name":"Kevin Kalinsky","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1669430310"},"summary":"Kevin Kalinsky is an Oncology physician. ClinicalTrials.gov lists 10 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":10,"shown":3,"withheld":7,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06460298","title":"ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"ProDa BioTech, LLC","source_url":"https://clinicaltrials.gov/study/NCT06460298","trial_url":"https://www.findmykol.com/trial/NCT06460298"},{"nct":"NCT06400251","title":"Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K)","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT06400251","trial_url":"https://www.findmykol.com/trial/NCT06400251"},{"nct":"NCT04439123","title":"Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT04439123","trial_url":"https://www.findmykol.com/trial/NCT04439123"}],"source":"trials"},"payments":{"company_count":19,"program_years":{"first":2021,"last":null},"rows_total":45,"shown":3,"withheld":42,"rows":[{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":4905,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669430310"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":4032.27,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669430310"},{"payer":"Genentech USA, Inc.","program_year":2025,"amount_usd":2887.61,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1669430310"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1669430310","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":61.5,"classes_total":3,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":38,"drugs":[{"name":"Anastrozole","share_pct":55.2},{"name":"Letrozole","share_pct":34.3},{"name":"Exemestane","share_pct":10.4}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":20.1,"drugs":[{"name":"Verzenio","share_pct":45.1},{"name":"Ibrance","share_pct":35.2},{"name":"Kisqali","share_pct":19.7}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":15,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":15,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":14}]},{"area":"Nervous system","share_pct":12.2,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":12.2,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":24}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":2014,"last":2017},"rows_total":4,"shown":3,"withheld":1,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R03CA208547","title":"Identifying leptomeningeal metastasis from breast cancer utilizing a novel immunocytochemical microfluidic device","fiscal_year":2017,"amount_usd":"80000","organization":"COLUMBIA UNIVERSITY HEALTH SCIENCES","source_url":"https://reporter.nih.gov/quickSearch/R03CA208547"},{"project":"R03CA208547","title":"Identifying leptomeningeal metastasis from breast cancer utilizing a novel immunocytochemical microfluidic device","fiscal_year":2016,"amount_usd":"80000","organization":"COLUMBIA UNIVERSITY HEALTH SCIENCES","source_url":"https://reporter.nih.gov/quickSearch/R03CA208547"},{"project":"R03CA186931","title":"Pre-Surgical trial of Metformin and Atorvastatin in Operable Breast Cancer","fiscal_year":2015,"amount_usd":"80000","organization":"COLUMBIA UNIVERSITY HEALTH SCIENCES","source_url":"https://reporter.nih.gov/quickSearch/R03CA186931"}],"source":"grants"},"contact":{"address_1":"161 FORT WASHINGTON AVENUE, 10TH FLOOR, ROOM 1069","address_2":"COLUMBIA UNIVERSITY MEDICAL CENTER","city":"New York","state":"NY","zip":"10032","phone":"212-305-1945","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1669430310","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":7,"payments":42,"funding":1}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-09-22","provider_certified":"2020-09-22","collected_at":"2026-11-02T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}